PMID: 17719933

Pall H, Zielenski J, Jonas MM, DaSilva DA, Potvin KM, Yuan XW, Huang Q, Freedman SD
Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function.
J Pediatr. 2007 Sep;151(3):255-9. Epub 2007 Jul 24., [PubMed]
Sentences
No. Mutations Sentence Comment
65 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:65:4
status: NEW
view ABCC7 p.Arg75Gln details
The R75Q variant was common in both groups of subjects and is currently not listed as a CF causing mutation, although its contribution to CF-like phenotypes cannot be excluded. Login to comment
70 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:70:88
status: NEW
view ABCC7 p.Arg75Gln details
The data indicate the following frequencies: IVS8T5, 3% to 5%, depending on population; R75Q, 3% to 6%, depending on population; 1716G ¡ A, 1% to 2% (personal communication from Julian Zielenski, Hospital for Sick Children, Toronto, Canada). Login to comment
90 ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:90:149
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:90:310
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:90:522
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:90:897
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Arg75Gln
X
ABCC7 p.Arg75Gln 17719933:90:1026
status: NEW
view ABCC7 p.Arg75Gln details
ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 17719933:90:679
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Glu725Lys
X
ABCC7 p.Glu725Lys 17719933:90:284
status: NEW
view ABCC7 p.Glu725Lys details
ABCC7 p.Gln1352His
X
ABCC7 p.Gln1352His 17719933:90:937
status: NEW
view ABCC7 p.Gln1352His details
Mutations/Variants Polymorphism 1540 locus T Tract Sweat chloride (mmol/L) ⌬Cl ؉ Iso (mV)* PSC 1 GG 7/7 20.2 -1.2 2 GG 7/7 19.7 -17.3 3 R75Q AA 7/7 14.8 -3.9 4 4521G/A(8T/9T) AA 7/7 19.4 -13.3 5 2694T/G AG 7/7 NP NP 6 GG 7/7 5.1 -12.5 7 NP 5.8 -17.8 8 AA 7/7 9.9 -12.8 9 E725K AG 7/7 56.3 -5.1 10 R75Q AA 7/7 30.3 -5.5 11 4006 - 200G/A, 1233A/T AA 7/9 32.1 -29 12 2694T/G AG 7/7 8.7 -2.4 13 4521G/A, 4700T8/9 AG 7/7 4.8 -3.8 14 1525 - 61A/G AG 7/9 45.3 -2.2 15 3030G/A GG 7/7 18.6 -0.45 16 AA 7/7 7.6 -4.5 17 R75Q AG 7/9 21.6 -1.8 18 1001 ϩ 11C/T AG 7/9 45 1.2 19 AA 7/7 11 -11.5 20 1716G ¡ A AG 7/7 18.9 -20.1 IBD 21 1001 ϩ 11C/T AG 7/9 8.9 -13 22 S1235R/2752 - 26A ¡ G 185 ϩ 324C/T AG 7/7 15 -15 23 AG 7/7 17.8 -20 24 IVS8T5 AA 5/7 4.8 -10.4 25 875 ϩ 40A/G, 125G/C GG 7/7 10.8 -30 26 AG 7/7 22.9 -10.5 27 IVS8T5 AG 5/7 15.1 NP 28 AG 7/7 20.1 -8 29 R75Q GG 7/7 10.1 -17 30 AA 7/7 14 NP 31 Q1352H 4521A(hom), 4700T8/8 AG 7/7 3.5 -35 32 AA 7/7 11.8 -8 33 125G/C AG 7/7 9.4 -33 34 R75Q/IVS8T5 1898 ϩ 152T/A AG 5/7 4 -14 Subjects with IBD were disease control subjects. Login to comment
91 ABCC7 p.Ser1235Arg
X
ABCC7 p.Ser1235Arg 17719933:91:40
status: NEW
view ABCC7 p.Ser1235Arg details
ABCC7 p.Glu725Lys
X
ABCC7 p.Glu725Lys 17719933:91:33
status: NEW
view ABCC7 p.Glu725Lys details
CFTR mutations shown in bold are E725K, S1235R, and 2752 - 26A ¡ G. Login to comment